Skip to main content
Caplight Logo









Genomcore

Genomcore

Private
Esplugues de LlobregatHealthcare & Life Scienceshttps://genomcore.com/

Last Round

VC Round

Dec 2, 2024

Total Funding Raised

$1.04M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Genomcore is a biotechnology company that provides a modular platform for biomedical data management, enabling the integration and analysis of genomic, clinical, and sensor data for precision medicine applications.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Platform-as-a-Service, Medical AI, Low-Code/No-Code

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting, Marketplace Commission

AI Layer

Application

Keywords

precision medicine platformlow-code platformbiomedical data platformgenomic data platformAI digital twinhealth data infrastructurebioinformatics platformmultimodal datagenomics cloudPaaSmedical AIno-code app builderpatient portals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomcore Comparables

Compare Genomcore with similar companies based on industry and business-model similarity.

Genomcore comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DNAnexus
80%
SeqOne
79%
BC Platforms
77%

Genomcore Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 2, 2024
GrantOct 17, 2022

Key People

Founding team and executive leadership

Oscar Flores Guri

Chief Executive Officer

Executive Team

Jordi Camí Montané

Chief Technology Officer

Executive Team

Sergi G.

Chief Financial Officer

Executive Team

Genomcore Investors

Notable investors and investment history

Genomcore investors
InvestorRounds
QVIDTVM ManagementVC Round
Barça Innovation HubVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 48% MoM.

  • Dec 2, 2024

    $5.25M round led by QVIDTVM Management

Genomcore Filings

Explore SEC and related filing metadata, where available.

Genomcore filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genomcore's valuation, stock price, and market status.

Is Genomcore a public or private company?

Genomcore is a private company.

What is the current stock price of Genomcore?

Genomcore is a private company with no public stock price. No recent secondary market data is available.

How much is Genomcore worth (valuation)?

Valuation information for Genomcore is not publicly available.

Can I buy Genomcore stock?

Genomcore shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genomcore's last funding round?

Genomcore's most recent funding round was VC Round on December 2, 2024.

Who are the main investors in Genomcore?

Key investors in Genomcore include QVIDTVM Management.

Will Genomcore IPO soon?

No public IPO plans have been announced for Genomcore.

How can I track Genomcore secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomcore's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEsplugues de Llobregat
Employee Range58
Year Founded2015
Last FundingDec 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?